# Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

> **NCT04583358** · PHASE2 · UNKNOWN · sponsor: **Applied Molecular Transport** · enrollment: 105 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** AMT-101 (oral)
- **OTHER:** Placebo (oral)

## Key facts

- **NCT ID:** NCT04583358
- **Lead sponsor:** Applied Molecular Transport
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-26
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2022-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04583358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04583358, "Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04583358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*